Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Journal of Translational Medicine
|
March 5, 2013
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
Paolo A Ascierto, Mariaelena Capone, Walter J Urba, et al.
Journal of Translational Medicine
|
October 2, 2024
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Alessandro Lavoro, Luca Falzone, Giuseppe Gattuso, et al.
Journal for Immunotherapy of Cancer
|
March 31, 2019
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
Paolo A Ascierto, Mariaelena Capone, Antonio M Grimaldi, et al.
International Journal of Molecular Sciences
|
August 10, 2024
Innate Immune Cells in Melanoma: Implications for Immunotherapy
Marialuisa Trocchia, Annagioia Ventrici, Luca Modestino, et al.
Journal for Immunotherapy of Cancer
|
July 18, 2018
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
Mariaelena Capone, Diana Giannarelli, Domenico Mallardo, et al.
Cancers
|
September 28, 2019
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin
Ciro Francesco Ruggiero, Debora Malpicci, Luigi Fattore, et al.
Cell Death & Disease
|
January 21, 2025
Role of the androgen receptor in melanoma aggressiveness
Marzia Di Donato, Costanza Maria Cristiani, Mariaelena Capone, et al.
Journal of Biomedicine & Biotechnology
|
January 7, 2009
Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy
Valerio Costa, Amelia Casamassimi, Katherine Esposito, et al.
Cell Death & Disease
|
March 13, 2024
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors
Domenico Liguoro, Rachele Frigerio, Arianna Ortolano, et al.
Frontiers in Immunology
|
February 17, 2022
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors
Costanza Maria Cristiani, Mariaelena Capone, Cinzia Garofalo, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Journal of Translational Medicine
|
March 5, 2013
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
Paolo A Ascierto, Mariaelena Capone, Walter J Urba, et al.
Journal of Translational Medicine
|
October 2, 2024
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Alessandro Lavoro, Luca Falzone, Giuseppe Gattuso, et al.
Journal for Immunotherapy of Cancer
|
March 31, 2019
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
Paolo A Ascierto, Mariaelena Capone, Antonio M Grimaldi, et al.
International Journal of Molecular Sciences
|
August 10, 2024
Innate Immune Cells in Melanoma: Implications for Immunotherapy
Marialuisa Trocchia, Annagioia Ventrici, Luca Modestino, et al.
Journal for Immunotherapy of Cancer
|
July 18, 2018
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
Mariaelena Capone, Diana Giannarelli, Domenico Mallardo, et al.
Cancers
|
September 28, 2019
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin
Ciro Francesco Ruggiero, Debora Malpicci, Luigi Fattore, et al.
Cell Death & Disease
|
January 21, 2025
Role of the androgen receptor in melanoma aggressiveness
Marzia Di Donato, Costanza Maria Cristiani, Mariaelena Capone, et al.
Journal of Biomedicine & Biotechnology
|
January 7, 2009
Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy
Valerio Costa, Amelia Casamassimi, Katherine Esposito, et al.
Cell Death & Disease
|
March 13, 2024
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors
Domenico Liguoro, Rachele Frigerio, Arianna Ortolano, et al.
Frontiers in Immunology
|
February 17, 2022
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors
Costanza Maria Cristiani, Mariaelena Capone, Cinzia Garofalo, et al.
Page
of 7